Brodey, J. F., W. G. Steiner, and H. E. Himwich: An electrographic study of psilocin and 4-methyl-α-methyl tryptamine (MP-809), J. Pharmacol. exp. Ther. 140, 8–18 (1963).
Brown, M. L., S. Gershon, W. J. Lang, and B. Korol: The effects of psychoactive drugs on the behavioural response to Ditran in dogs. Arch. int. Pharmacodyn. 160, 407–423 (1966).
Corne, S. J., R. W. Pickering, and B. T. Warner: A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Brit. J. Pharmacol. 20, 106–120 (1963).
Divry, P., J. Bobon et J. Collard: Rapport sur l'activé neuro-psychopharmacologique du halopéridol (R 1625). Acta neurol. belg. 60, 7–19 (1960).
Fabing, H. D., and R. J. Hawkins: Intravenous bufotenine injection in the human being. Science 123, 886–887 (1956).
Finney, D. J.: Statistical method in biological assay, 2nd edition. London: C. Griffin & Co. Ltd. 1964.
Friedhoff, A. J., and L. E. Hollister: Effects of 3,4-dimethoxyphenylethylamine in man. Nature (Lond.) 210, 1377–1378 (1966a).
— —: Comparison of the metabolism of 3,4-dimethyloxphenylethylamine and mescaline in humans. Biochem. Pharmacol. 15, 269–273 (1966b).
Gaddum, J. H.: Ciba Foundation Symposium on Hypotension. London: J. & A. Churchill Ltd. 1954.
Gershon, S., and J. Olariu: JB 329—a new psychotomimetic. Its antagonism by tetrahydroaminacrine and its comparison with LSD, mescaline and Sernyl. J. Neuropsychiat. 1, 283–292 (1960).
Goodman, L. S., and A. Gilman: The pharmacological basis of therapeutics, 3rd edition. New York: Macmillan 1965.
Gool, R. Y., and H. L. Clarke: Anaesthesia for under doctored areas. Anaesthesia 19, 265–270 (1964).
Gyermek, L., and T. Sumi: Potentiating actions of indolealkylamines and lysergic acid diethylamide on reflexes elicited by 5-hydroxytryptophan. Proc. Soc. exp. Biol. (N.Y.) 114, 436–439 (1963).
Holmberg, G., and S. Gershon: Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia (Berl.) 2, 93–106 (1961).
Isbell, H.: Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia (Berl.) 1, 29–38 (1959).
—, A. B. Wolbach jr., A. Wickler, and E. J. Milner: Cross tolerance between LSD and psilocybin. Psychopharmacologia (Berl.) 2, 147–159 (1961).
Jacob, J., and C. Lafille: Pharmacological characterization and detection of hallucinogenic substances (1) Hyperthermic activity in rabbits. Arch. int. Pharmacodyn. 145, 528–545 (1963).
— —, G. Loiseau, P. Echinard-Garin et C. Barthelemy: Recherche d'équivalents expérimentaux au pouvoir hallucinogène. Med. exp. (Basel) 7, 296–304 (1962).
Jacobsen, E.: The clinical pharmacology of the hallucinogens. Clin. Pharmacol. Ther. 4, 480–503 (1963).
Johnstone, M., V. Evans, and S. Baigel: Sernyl (Cl-395) in clinical anaesthesia. Brit. J. Anaesth. 31, 433–439 (1959).
Knoll, J., E. S. Vizi, and Z. Ecseri: Psychomimetic methylamphetamine derivatives. Arch. int. Pharmacodyn. 159, 442–451 (1966).
Lipman, V. C., P. S. Shurrager, and L. G. Abood: Effect of anticholinergic psychotomimetics on motor activity and body temperature. Arch. int. Pharmacodyn. 146, 174–191 (1963).
Murphree, H. B., R. H. Dippy, E. H. Jenney, and C. E. Pfeiffer: Effects in normal man of α-methyltryptamine and α-ethyltryptamine. Clin. Pharmacol. Ther. 2, 722–726 (1961).
Pfeiffer, C. C., H. B. Murphree, E. H. Jenney, M. G. Robertson, and A. H. Randall: Hallucinatory effect in man of acetylcholine inhibitors. Neurology (Minneap.) 9, 249–250 (1959).
Resnick, O., D. M. Krus, and M. Raskin: LSD-25 action in normal subjects treated with a monoamine oxidase inhibitor. Life Sci. 3, 1207–1214 (1964).
Rosenberg, D. E., H. Isbell, E. J. Miner, and C. R. Logan: The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia (Berl.) 5, 217–227 (1964).
Rothlin, E.: Pharmacology of lysergic acid diethylamide and some of its related compounds. J. Pharm. Pharmacol. 9, 569–587 (1957).
Sai-Halasz, A.: The effect of MAO inhibition on the experimental psychoses induced by dimethyltryptamine. Psychopharmacologia (Berl.) 4, 385–388 (1963).
Schueler, F. W.: The effects of succinate in mescaline hallucinations. J. Lab. clin. Med. 33, 1297–1303 (1948).
Schweigerdt, A. K., and H. E. Himwich: An electrographic study of hypotension and 5-hydroxytryptophan. J. Pharmacol. exp. Ther. 144, 253–259 (1964).
—, A. H. Stewart, and H. E. Himwich: An electrographic study of d-lysergic acid diethylamide and nine congeners. J. Pharmacol. exp. Ther. 151, 353–359 (1966).
Shulgin, A. T.: Psychotomimetic agents related to mescaline. Experientia (Basel) 19, 127–128 (1963).
—: Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines. Experientia (Basel) 20, 366–367 (1964).
Sollman, T.: A manual of pharmacology, 8th edition. Philadelphia: W. B. Saunders & Co. 1957.
Stevenson, I., and A. J. Sanchez: The antidotal action of sodium succinate in the mescaline psychosis. Amer. J. Psychiat. 114, 328–332 (1957).
Takeo, Y., and H. E. Himwich: Mescaline, 3,4-dimethoxyphenylethylamine and adrenaline: sites of electroencephalographic arousal. Science 150, 1309–1310 (1965).
Turner, W. J., and S. Merlis: Effect of some indolealkylamines on man. Arch. Neurol. Psychiat. (Chic.) 81, 121–129 (1959).
Wolbach, A. B., jr., H. Isbell, and E. J. Miner: Cross tolerance between mescaline and LSD-25. Psychopharmacologia (Berl.) 3, 1–14 (1962).
Woolley, D. W.: The biochemical bases of psychoses. New York: John Wiley & Sons, Inc. 1962.
—, and E. Shaw: A biochemical and pharmacological suggestion about certain mental disorders. Proc. nat. Acad. Sci. (Wash.) 40, 228–231 (1954).
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4